HWAM
BCRX icon

Hennion & Walsh Asset Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Hennion & Walsh Asset Management’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$651K Buy
2025
Q2 		$452K Buy